This presentation explores the evolving landscape of interventional therapies for the treatment of refractory headaches.

The presentation is structured to cover the historical context of headache treatments, modern interventional methodologies, patient selection criteria, the prevalence of headache disorders, and safety considerations related to these interventions.

Historical Context and Evolution of Treatments
Importance and Prevalence of Headache Disorders
Interventional Treatment Modalities
Specific Interventional Techniques and Their Efficacy
Safety Considerations in Interventional Procedures
Teamwork across specialties—including neurology, primary care, and pain management—to optimize patient outcomes in headache management
Conclusion and Future Directions

Accreditation & Designation

Release date: This activity was released 3/3/2023.

Termination date: The content of this activity remains eligible for CME Credit until 3/2/2026, unless reviewed or amended prior to this date.

Claiming Credit: Watch the entire presentation and complete the Improvement Plan/Evaluation.

Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Neurovations Education designates this other activity (blended learning) for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes discussions of unlabeled or investigational uses of commercial and/or developmental products.

This activity includes discussions and explorations of new and evolving topics. Such inclusion includes adequate justifications of statements based upon current science, evidence and clinical reasoning.

Disclosure of Financial Relationships

[Presenter] Dmitri Souza discloses the following financial relationships within the past 24 months: Research: Scilex: Consulting, Research Funding; AbbVie: Consulting, Research Funding: LECOM

No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).